Biocleave Overview
- Founded
-
2002

- Status
-
Private
- Employees
-
14

- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$1.35M
- Investors
-
5
Biocleave General Information
Description
Operator of an industrial biotechnology platform designed to exploit the protein production capabilities of versatile microbes. The company's platform uses fermentation to produce renewable butanol from feedstocks including corn and cellulosic feedstocks, enabling pharmaceutical companies to access renewable butanol used in paints, coatings, adhesives, inks, plastics, pharmaceuticals, household cleaners, and personal care products.
Contact Information
Website
www.biocleave.com
Formerly Known As
Green Biologics, Green Biotechnologies
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Industrial Chemicals
Other Chemicals and Gases
Primary Office
- 154AH Brook Drive
- Milton Park, Oxfordshire
- Abingdon OX14 4SD
- England, United Kingdom
+44 01235 000000
Biocleave Timeline
Biocleave Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
25. Later Stage VC | 02-Mar-2022 | $1.35M | 00.000 | Completed | Generating Revenue | |
24. Later Stage VC (Series 1) | 21-Dec-2020 | 00.000 | 00.000 | Completed | Generating Revenue | |
23. Grant | 01-Oct-2020 | 000.00 | Completed | Generating Revenue | ||
22. IBO | 01-Jan-2019 | 00000 | Completed | Generating Revenue | ||
21. Later Stage VC | 10-Oct-2018 | 000.00 | 00000 | 000.00 | Completed | Generating Revenue |
20. Grant | 01-Jun-2018 | 00000 | 00000 | Completed | Generating Revenue | |
19. Grant | 01-Apr-2018 | 00000 | 00000 | Completed | Generating Revenue | |
18. Debt - General | 31-Dec-2017 | 000.00 | 00000 | Completed | Generating Revenue | |
17. Grant | 01-Sep-2017 | $403K | $160M | Completed | Generating Revenue | |
16. Grant | 01-Aug-2017 | $433K | $160M | Completed | Generating Revenue |
Biocleave Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Ordinary | 00,000,000 | 00.000000 | 00.0 | 00.0 | 00 | 00.0 | 0.000 | |
Ordinary | 00,000,000 | 00.000000 | 00.0 | 00.0 | 00 | 00.0 | 00.000 | |
Ordinary | 00,000,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 00.000 | |
C1 Ordinary | 00,000,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 0.000 | |
C1 Ordinary | 00,000,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 00.000 | |
Ordinary | 000,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 0.000 | |
B1 Ordinary | 0,000,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 0.000 | |
B Ordinary | 00,000,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 0.000 | |
Ordinary | 1,116,750 | $0.000131 | $2.57 | $2.57 | 1x | $2.57 | 0.63% | |
B Ordinary | 9,224,676 | $0.000131 | $2.14 | $2.14 | 1x | $2.14 | 5.18% |
Biocleave Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Financing
Details
Operator of an industrial biotechnology platform designed to exploit the protein production capabilities of versatile mi
Biotechnology
Abingdon, United Kingdom
14
As of 2023
00.000
0000000000 0
00.000
Biocleave Competitors (8)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Arzeda | Venture Capital-Backed | Seattle, WA | 00 | 000.00 | 00000000000 | 000.00 |
0000000000 0000000 | Corporation | Clayton, MO | 000 | 000000&0 | ||
0000 000000 000 | Formerly VC-backed | Missoula, MT | 0 | 00.000 | 000000&0 | 00.000 |
000000 | Formerly VC-backed | Emeryville, CA | 0000 | 00.000 | 0000000000. | |
000000000 | Corporation | Bagsvaerd, Denmark | 0000 | 00000000 |
Biocleave Patents
Biocleave Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20210189325-A1 | Processes involving clostridium saccharoperbutylacetonicum | Active | 13-Oct-2017 | 00000000 | |
US-11584914-B2 | Processes for producing organic solvents using clostridium saccharoperbutylacetonicum | Active | 13-Oct-2017 | 00000000 | 00 |
EP-3694983-A1 | Processes involving clostridium saccharoperbutylacetonicum | Pending | 13-Oct-2017 | 00000000 | |
GB-201716845-D0 | Process | Inactive | 13-Oct-2017 | 00000000 | |
GB-201816751-D0 | Process | Inactive | 13-Oct-2017 | C12N1/20 |
Biocleave Executive Team (15)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Elizabeth Jenkinson Ph.D | Chief Executive Officer & Board Member | ||
Karen Stanley | Board Member and Finance Director | ||
Sean Sutcliffe | Chairman |
Biocleave Board Members (16)
Name | Representing | Role | Since |
---|---|---|---|
David Denny | Self | Board Member | 000 0000 |
Elizabeth Jenkinson Ph.D | Biocleave | Chief Executive Officer & Board Member | 000 0000 |
Karen Stanley | Biocleave | Board Member and Finance Director | 000 0000 |
Sean Sutcliffe | Biocleave | Chairman | 000 0000 |
Biocleave Signals
Biocleave Investors (5)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Egle B. Thomas | Angel (individual) | Minority | 000 0000 | 000000 0 | |
Longwall Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | |
Wren Capital | Angel Group | Minority | 000 0000 | 000000 0 | |
Tennenbaum Capital Partners | Asset Manager | Minority | 000 0000 | 000000 0 | |
Convergence Group | Corporation | Minority | 000 0000 | 000000 0 |
Biocleave Acquisitions (2)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
0000000 00 00 | 23-Dec-2014 | 0000000000 | Industrial Chemicals | 0000 0000 | |
Butylfuel | 20-Jan-2012 | Merger/Acquisition | Environmental Services (B2B) |